From:	McClendon, Capri R
Sent:	Thursday, April 03, 2003 2:04 PM
To:	Butler, Jennie C
Cc:	CDER EXSEC; Clarke, Elizabeth
Subject:	FW: Priority Correspondence; Trac #:  0301481

Importance:	High

THE FOLLOWING CONTROL IS BEING RE-ROUTED FROM HFD-1 TO HFA-305.
SEE ROUTING SLIP REMARKS FOR DETAILS.  THANK YOU.


FROM:		Chuck Muth, Citizen Outreach

SYNOPSIS:	Urges the FDA to deny the petition submitted by Wellpoint Health Network to switch a number of prescription antihistamines to OTC.


Attached is priority correspondence which requires immediate action.  

If you need additional information, please call the ExecSec Contact listed on the control sheet.

Thank You, FDA/OC Executive Secretariat